A report was received on (b)(6) 2023 from the caregiver of a 52 year old male patient with a medical history including hypertension and end stage renal disease who stated the patient previously had a hypersensitivity type response during hemodialysis therapy, date not provided.Additional information was received on 06 oct 2023 from the home therapy nurse (htn), who stated the patient experienced generalized urticaria within five minutes of beginning his first in-center hemodialysis treatment on (b)(6) 2023.Per the htn, the patient was treated with 25mg of intravenous diphenhydramine (benadryl) and symptoms resolved.The patient continues to with nxstage therapy and no further hypersensitivity type reactions have been reported.
|